A phosphorylation switch on RbBP5 regulates histone H3 Lys4 methylation

Genes and Development

Volumn 29, Issue 2, 2015, Pages 123-128

  Zhang, Pamela ^a   Chaturvedi, Chandra Prakash ^b,c   Tremblay, Veronique ^a   Cramet, Myriam ^a   Brunzelle, Joseph S ^d   Skiniotis, Georgios ^d,e   Brand, Marjorie ^b,c   Shilatifard, Ali ^d   Couture, Jean François ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chromatin; COMPASS; Epigenetics; Histone H3 Lys4; Methylation

Indexed keywords

HISTONE H3; LYSINE METHYLTRANSFERASE 2; METHYLTRANSFERASE; PROTEIN; RBBP5 PROTEIN; UNCLASSIFIED DRUG; ASH2L PROTEIN, MOUSE; DNA BINDING PROTEIN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN BINDING; RBBP5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ARTICLE; CATALYSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ERYTHROID CELL; HISTONE METHYLATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; CYTOLOGY; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; METHYLATION; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CRYSTALLIZATION; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ERYTHROID CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; METHYLATION; METHYLTRANSFERASES; MODELS, MOLECULAR; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 84921533431     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.254870.114     Document Type: Article

References (38)

1. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. 2007. New nomenclature for chromatin-modifying enzymes. Cell 131: 633–636.
2. Avdic V, Zhang P, Lanouette S, Groulx A, Tremblay V, Brunzelle J, Couture JF. 2011. Structural and biochemical insights into MLL1 core complex assembly. Structure 19: 101–108.
3. Cao F, Chen Y, Cierpicki T, Liu Y, Basrur V, Lei M, Dou Y. 2010. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS ONE 5: e14102.
4. Chen Y, Wan B, Wang KC, Cao F, Yang Y, Protacio A, Dou Y, Chang HY, Lei M. 2011. Crystal structure of the N-terminal region of human Ash2L shows a winged-helix motif involved in DNA binding. EMBO Rep 12: 797–803.
5. Chen Y, Cao F,Wan B, Dou Y, Lei M. 2012. Structure of the SPRY domain of human Ash2L and its interactions with RbBP5 and DPY30. Cell Res 22: 598–602.
6. Cheng J, Blum R, Bowman C, Hu D, Shilatifard A, Shen S, Dynlacht BD. 2014. A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers. Mol Cell 53: 979–992.
7. Cho YW, Hong T, Hong S, Guo H, Yu H, Kim D, Guszczynski T, Dressler GR, Copeland TD, Kalkum M, et al. 2007. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 282: 20395–20406.
8. Christensen GL, Kelstrup CD, Lyngso C, Sarwar U, Bogebo R, Sheikh SP, Gammeltoft S, Olsen JV, Hansen JL. 2010. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 9: 1540–1553.
9. Couture JF, Skiniotis G. 2013. Assembling a COMPASS. Epigenetics 8: 349–354.
10. Daniel JA, Santos MA, Wang Z, Zang C, Schwab KR, Jankovic M, Filsuf D, Chen HT, Gazumyan A, Yamane A, et al. 2010. PTIP promotes chromatin changes critical for immunoglobulin class switch recombination. Science 329: 917–923.
11. Dehe PM, Dichtl B, Schaft D, Roguev A, Pamblanco M, Lebrun R, Rodr_ıguez-Gil A, Mkandawire M, Landsberg K, Shevchenko A, et al. 2006. Protein interactions within the Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation. J Biol Chem 281: 35404–35412.
12. Demers C, Chaturvedi CP, Ranish JA, Juban G, Lai P, Morle F, Aebersold R, Dilworth FJ, Groudine M, Brand M. 2007. Activator-mediated recruitment of the MLL2 methyltransferase complex to the b-globin locus. Mol Cell 27: 573–584.
13. Dharmarajan V, Lee JH, Patel A, Skalnik DG, Cosgrove MS. 2012. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases. J Biol Chem 287: 27275–27289.
14. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, Allis CD, Roeder RG. 2006. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13: 713–719.
15. Herz HM, Mohan M, Garruss AS, Liang K, Takahashi YH, Mickey K, Voets O, Verrijzer CP, Shilatifard A. 2012. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev 26: 2604–2620.
16. Hu D, Gao X, Morgan MA, Herz HM, Smith ER, Shilatifard A. 2013. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol 33: 4745– 4754.
17. Issaeva I, Zonis Y, Rozovskaia T, Orlovsky K, Croce CM, Nakamura T, Mazo A, Eisenbach L, Canaani E. 2007. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 27: 1889–1903.
18. Krogan NJ, Dover J, Khorrami S, Greenblatt JF, Schneider J, Johnston M, Shilatifard A. 2002. COMPASS, a histone H3 (lysine 4) methyltransferase required for telomeric silencing of gene expression. J Biol Chem 277: 10753–10755.
19. Lee J, Saha PK, Yang QH, Lee S, Park JY, Suh Y, Lee SK, Chan L, Roeder RG, Lee JW. 2008. Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci 105: 19229–19234.
20. Liu H, Takeda S, Kumar R, Westergard TD, Brown EJ, Pandita TK, Cheng EHY, Hsieh JJD. 2010. Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature 467: 343–346.
21. Miller T, Krogan NJ, Dover J, Erdjument-Bromage H, Tempst P, Johnston M, Greenblatt JF, Shilatifard A. 2001. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci 98: 12902–12907.
22. Morgan MA, Shilatifard A. 2013. Drosophila SETs its sights on cancer: Trr/MLL3/4 COMPASS-like complexes in development and disease. Mol Cell Biol 33: 1698–1701.
23. Muslin AJ, Tanner JW, Allen PM, Shaw AS. 1996. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889–897.
24. Odho Z, Southall SM, Wilson JR. 2010. Characterization of a novel WDR5-binding site that recruits RbBP5 through a conserved motif to enhance methylation of histone H3 lysine 4 by mixed lineage leukemia protein-1. J Biol Chem 285: 32967–32976.
25. Patel A, Dharmarajan V, Vought VE, Cosgrove MS. 2009. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem 284: 24242–24256.
26. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, Bailey DJ, Swaney DL, Tervo MA, Bolin JM, Ruotti V, et al. 2011. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 8: 821–827.
27. Rittinger K, Budman J, Xu J, Volinia S, Cantley LC, Smerdon SJ, Gamblin SJ, Yaffe MB. 1999. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14- 3-3 in ligand binding. Mol Cell 4: 153–166.
28. Roguev A, Schaft D, Shevchenko A, Pijnappel WW, Wilm M, Aasland R, Stewart AF. 2001. The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J 20: 7137–7148.
29. Sarvan S, Avdic V, Tremblay V, Chaturvedi CP, Zhang P, Lanouette S, Blais A, Brunzelle JS, Brand M, Couture JF. 2011. Crystal structure of the trithorax group protein ASH2L reveals a forkhead-like DNA binding domain. Nat Struct Mol Biol 18: 857–859.
30. Shilatifard A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem 81: 65–95.
31. Shiromizu T, Adachi J, Watanabe S, Murakami T, Kuga T, Muraoka S, Tomonaga T. 2013. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12: 2414–2421.
32. South PF, Fingerman IM, Mersman DP, Du HN, Briggs SD. 2010. A conserved interaction between the SDI domain of Bre2 and the Dpy- 30 domain of Sdc1 is required for histone methylation and gene expression. J Biol Chem 285: 595–607.
33. Southall SM, Wong PS, Odho Z, Roe SM, Wilson JR. 2009. Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks. Mol Cell 33: 181–191.
34. Steward MM, Lee JS, O’Donovan A,Wyatt M, Bernstein BE, Shilatifard A. 2006. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 13: 852–854.
35. Wu M, Wang PF, Lee JS, Martin-Brown S, Florens L, Washburn M, Shilatifard A. 2008. Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. Mol Cell Biol 28: 7337–7344.
36. Wu L, Lee SY, Zhou B, Nguyen UT, Muir TW, Tan S, Dou Y. 2013. ASH2L regulates ubiquitylation signaling to MLL: trans-regulation of H3 K4 methylation in higher eukaryotes. Mol Cell 49: 1108–1120.
37. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ. 1995. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505–508.
38. Zhang P, Lee H, Brunzelle JS, Couture JF. 2012. The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases. Nucleic Acids Res 40: 4237–4246